MIR4458HG: A Potential Drug Target and Biomarker (G100505738)
MIR4458HG: A Potential Drug Target and Biomarker
Mir4458HG, a gene encoding for a protein known as heat shock protein (HSP70), has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique expression pattern in various tissues and its ability to interact with other proteins make it an attractive target for researchers to study.
The HSP70 family of proteins plays a crucial role in the regulation of protein homeostasis, which is the maintaining of the proper concentration and activity of proteins in the cells. HSP70 proteins can interact with a wide range of protein partners and have been involved in various cellular processes, including stress response, DNA repair, and cell signaling.
Mir4458HG, a full-length human HSP70 protein, is a 12.9 kDa protein that is expressed in various tissues, including the brain, heart, liver, and muscle. It is highly expressed in the heart and has been shown to be involved in cardiac function, including contractility and cardiac hypertrophy. HSP70 has also been shown to play a role in various signaling pathways, including the TGF-β pathway, which is involved in cell growth, differentiation, and survival.
Mir4458HG has also been shown to interact with several protein partners, including the transcription factor, p53. p53 is a well-known protein that plays a crucial role in the regulation of DNA repair and has been implicated in various diseases, including cancer. The interaction between Mir4458HG and p53 suggests that HSP70 may be a negative regulator of p53, which would have implications for the regulation of cellular processes, including cell growth, apoptosis, and DNA repair.
Furthermore, Mir4458HG has been shown to interact with the protein, heat shock factor (HSF), which is a protein that is involved in the regulation of protein homeostasis, including the expression of HSP70 proteins. This interaction suggests that HSP70 may be a target for drugs that can modulate HSF function, which could have implications for the regulation of protein homeostasis and various cellular processes.
In addition to its potential role in the regulation of protein homeostasis, Mir4458HG has also been shown to be involved in various signaling pathways, including the Wnt signaling pathway. Wnt is a signaling pathway that is involved in the regulation of cell growth, differentiation, and survival, and has been implicated in various diseases, including cancer. The interaction between Mir4458HG and the Wnt receptor, FBN1, suggests that HSP70 may be a target for drugs that can modulate Wnt signaling pathway.
Mir4458HG has also been shown to interact with the protein, S100, which is a protein that is involved in the regulation of protein-protein interactions and has been implicated in various diseases, including neurodegenerative diseases. The interaction between Mir4458HG and S100 suggests that HSP70 may be a target for drugs that can modulate protein-protein interactions.
In conclusion, Mir4458HG is a protein that has been identified as a potential drug target and biomarker for various diseases. Its unique expression pattern and its interaction with several protein partners suggest that it may be involved in various cellular processes, including stress response, DNA repair, and cell signaling. Further research is needed to determine the role of HSP70 in these processes and to develop drugs that can modulate its function.
Protein Name: MIR4458 Host Gene
The "MIR4458HG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4458HG comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652
